title: Neoadjuvant Therapy in Breast Cancer as a Basis for Drug Approval.
authors.affiliation: Department of Biostatistics, University of Texas MD Anderson Cancer Center, Houston.
authors.forename: Donald A
authors.initials: DA
authors.lastname: Berry
authors.affiliation: Memorial Sloan Kettering Cancer Center, New York, New York.
authors.forename: Clifford A
authors.initials: CA
authors.lastname: Hudis
mesh_terms: D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000401:mortality / Q000473:pathology; D003627:Data Interpretation, Statistical; D018450:Disease Progression; D018572:Disease-Free Survival; D017277:Drug Approval; D005260:Female; D006801:Humans; D020360:Neoadjuvant Therapy / Q000009:adverse effects / Q000401:mortality; D009364:Neoplasm Recurrence, Local; D015203:Reproducibility of Results; D018570:Risk Assessment; D012307:Risk Factors; D016019:Survival Analysis; D013997:Time Factors; D016896:Treatment Outcome; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D000970:Antineoplastic Agents